Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
agouti
(a) locus acts within the microenvironment of the hair follicle to regulate coat color pigmentation in the mouse. We have characterized a gene encoding a novel 131 amino acid protein that we propose is the one gene associated with the
agouti
locus. This gene is normally expressed in a manner consistent with a locus function, and, more importantly, its structure and expression are affected by a number of representative alleles in the
agouti
dominance hierarchy. In addition, we found that the pleiotropic effects associated with the lethal yellow (Ay) mutation, which include pronounced obesity,
diabetes
, and the development of neoplasms, are accompanied by deregulated overexpression of the
agouti
gene in numerous tissues of the adult animal.
...
PMID:Molecular characterization of the mouse agouti locus. 147 52
The
agouti
locus on mouse chromosome 2 encodes a secreted cysteine-rich protein of 131 amino acids that acts as a molecular switch to instruct the melanocyte to make either yellow pigment (phaeomelanin) or black pigment (eumelanin). Mutations that up-regulate
agouti
expression are dominant to those causing decreased expression and result in yellow coat color. Other associated effects are obesity,
diabetes
, and increased susceptibility to tumors. To try to define important functional domains of the
agouti
protein, we have analyzed the molecular defects present in a series of recessive viable
agouti
mutations. In total, six alleles (amJ, au, ada, a16H, a18H, ae) were examined at both the RNA and DNA level. Two of the alleles, a16H and ae, result from mutations in the
agouti
coding region. Four alleles (amJ, au, a18H, and ada) appear to represent regulatory mutations that down-regulate
agouti
expression. Interestingly, one of these mutations, a18H, also appears to cause an immunological defect in the homozygous condition. This immunological defect is somewhat analogous to that observed in motheaten (me) mutant mice. Short and long-range restriction enzyme analyses of homozygous a18H DNA are consistent with the hypothesis that a18H results from a paracentric inversion where one end of the inversion maps in the 5' regulatory region of
agouti
and the other end in or near a gene that is required for normal immunological function. Cloning the breakpoints of this putative inversion should allow us to identify the gene that confers this interesting immunological disorder.
...
PMID:Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. 763 90
The mouse
agouti
gene encodes an 131 amino acid paracrine signaling molecule that instructs hair follicle melanocytes to switch from making black to yellow pigment. Expression of
agouti
during the middle part of the hair growth cycle in wild-type mice produces a yellow band on an otherwise black hair. The ubiquitous unregulated expression of
agouti
in mice carrying dominant yellow alleles is associated with pleiotropic effects including increased yellow pigment in the coat, obesity,
diabetes
and increased tumor susceptibility. Agouti shows no significant homology to known genes, and the molecular analysis of
agouti
alleles has shed little new light on the important functional elements of the
agouti
protein. In this paper, we show that
agouti
expression driven by the human beta-ACTIN promoter produces obese yellow transgenic mice and that this can be used as an assay for
agouti
activity. We used this assay to evaluate a point mutation associated with the a16H allele within the region encoding
agouti
's putative signal sequence and our results suggest that this mutation is sufficient to cause the a16H phenotype. Thus, in vitro mutagenesis followed by the generation of transgenic mice should allow us to identify important functional elements of the
agouti
protein.
...
PMID:A transgenic mouse assay for agouti protein activity. 763 91
The mouse
agouti
coat color gene encodes a novel paracrine signaling molecule whose pulsatile expression produces a characteristic pattern of banded pigment in individual hairs. Several spontaneous
agouti
alleles produce adult-onset obesity and
diabetes
, and have provided important single-gene animal models for alterations in energy metabolism. Utilizing linkage groups conserved between mice and humans, we have cloned the human homolog of the mouse
agouti
gene from a human chromosome 20 yeast artificial chromosome known to contain S-adenosyl homocysteine hydrolase (AHCY). The human
agouti
gene, named Agouti Signaling Protein (ASP), encodes a 132 amino acid protein, the mRNA for which is expressed in testis, ovary, and heart, and at lower levels in liver, kidney, and foreskin. As predicted by the interactions of mouse
agouti
with the extension gene (which encodes the melanocyte receptor for alpha-melanocyte stimulating hormone [alpha-MSH]), expression of ASP in transgenic mice produces a yellow coat, and expression of ASP in cell culture blocks the alpha-MSH-stimulated accumulation of cAMP in mouse melanoma cells. The localization of ASP relative to other loci on chromosome 20 excludes it as a candidate for the MODY1 locus, a gene responsible for one form of early-onset non-insulin-dependent
diabetes mellitus
or maturity-onset
diabetes
of the young. The expression of ASP in human tissues suggests a function for
agouti
homologs in species that do not exhibit the characteristic phenotype of banded hairs.
...
PMID:Structure and function of ASP, the human homolog of the mouse agouti gene. 775 71
Mice that carry the lethal yellow (Ay) or viable yellow (Avy) mutation, two dominant mutations of the
agouti
(a) gene in mouse chromosome 2, exhibit a phenotype that includes yellow fur, marked obesity, a form of type II
diabetes
associated with insulin resistance, and an increased susceptibility to tumor development. Molecular analyses of these and several other dominant "obese yellow" a-locus mutations suggested that ectopic expression of the normal
agouti
protein gives rise to this complex pleiotropic phenotype. We have now tested this hypothesis directly by generating transgenic mice that ectopically express an
agouti
cDNA clone encoding the normal
agouti
protein in all tissues examined. Transgenic mice of both sexes have yellow fur, become obese, and develop hyperinsulinemia. In addition, male transgenic mice develop hyperglycemia by 12-20 weeks of age. These results demonstrate conclusively that the ectopic
agouti
expression is responsible for most, if not all, of the phenotypic traits of the dominant, obese yellow mutants.
...
PMID:Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. 776 89
The
agouti
locus was first identified as a result of its effects on the type and temporal deposition of coat color pigments in mammals. Many mutations at the murine
agouti
locus have now been found, some of which not only affect coat color, but also interfere with diverse biological processes leading to
diabetes
, obesity, tumor susceptibility and embryonic lethality. Correlations between the genotype and phenotype of
agouti
mutants, as well as reasons for the pleiotropy of effects caused by
agouti
mutations, have begun to unfold with the molecular cloning of the
agouti
gene and its surrounding genomic region.
...
PMID:The agouti gene: turned on to yellow. 787 91
The
agouti
gene normally confers the wild-type coat color of mice. Dominant mutations at the
agouti
locus result in a pleiotropic syndrome that is characterized by excessive amounts of yellow pigment in the coat, obesity, a non-insulin-dependent diabetic-like condition, and the propensity to form a variety of tumors. Here, we describe a new dominant mutation at the
agouti
locus in which an intracisternal A-particle (IAP) has integrated in an antisense orientation immediately 5' of the first coding exon of the gene. This mutation, which we have named Aiapy, results in the ectopic expression of the
agouti
gene through the utilization of a cryptic promoter within the IAP 5' long terminal repeat (LTR). The coat color of Aiapy/-mice ranges from solid yellow to a pigment pattern that is similar to wild type (pseudoagouti), and the expressivity of this mutant phenotype varies with parental inheritance. Those offspring with a yellow coat ectopically express
agouti
mRNA at high levels and exhibit marked obesity, whereas pseudoagouti mice express
agouti
mRNA at a very low level and their weights do not differ from wild-type littermates. Data are presented to show that the differential expressivity of the Aiapy allele is correlated with the methylation status of the inserted IAP 5' LTR. These data further support the hypothesis that in dominant yellow mutations at the
agouti
locus, it is the ubiquitous expression of the wild-type
agouti
coding sequence that is responsible for the yellow coat color, obesity,
diabetes
, and tumorigenesis.
...
PMID:Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage. 792 45
The
agouti
(a) locus in mouse chromosome 2 normally regulates coat color pigmentation. The mouse
agouti
gene was recently cloned and shown to encode a distinctive 131-amino acid protein with a consensus signal peptide. Here we describe the cloning of the human homolog of the mouse
agouti
gene using an interspecies DNA-hybridization approach. Sequence analysis revealed that the coding region of the human
agouti
gene is 85% identical to the mouse gene and has the potential to encode a protein of 132 amino acids with a consensus signal peptide. Chromosomal assignment using somatic-cell-hybrid mapping panels and fluorescence in situ hybridization demonstrated that the human
agouti
gene maps to chromosome band 20q11.2. This result revealed that the human
agouti
gene is closely linked to several traits, including a locus called MODY (for maturity onset
diabetes
of the young) and another region that is associated with the development of myeloid leukemia. Initial expression studies with RNA from several adult human tissues showed that the human
agouti
gene is expressed in adipose tissue and testis.
...
PMID:Molecular structure and chromosomal mapping of the human homolog of the agouti gene. 793 87
Agouti expression during the middle portion of the mouse hair growth cycle induces melanocytes to synthesize yellow instead of black pigment, generating black hairs with a yellow band. Dominant
agouti
alleles increase the amount of yellow pigment in the coat and are associated with pleiotropic effects including obesity,
diabetes
and increased tumor susceptibility. Four dominant
agouti
alleles (Aiapy, Aiy, and Avy) were recently shown to result from insertions that cause ubiquitous expression of chimeric transcripts encoding a wild-type
agouti
protein(1,2). Three insertions were identified as intracisternal A-particles, which helps explain the variable coat colors and parental imprinting effects associated with some dominant
agouti
alleles.
...
PMID:The molecular basis for dominant yellow agouti coat color mutations. 798 Apr 72
Lethal yellow (Ay) is a mutation at the mouse
agouti
(a) locus that is associated with an all-yellow coat color, obesity,
diabetes
, tumors in heterozygotes, and preimplantation embryonic lethality in homozygotes. Previously, we cloned and characterized the wild-type
agouti
gene and demonstrated that it expresses a 0.8-kb mRNA in neonatal skin. In contrast, Ay expresses a 1.1-kb transcript that is ectopically overexpressed in all tissues examined. The Ay mRNA is identical to the wild-type a transcript for the entire coding region, but the 5'-untranslated sequence of the a gene has been replaced by novel sequence. Here, we demonstrate that the novel 5' sequence in the Ay mRNA corresponds to the 5'-untranslated sequence of another gene that is normally tightly linked to a in mouse chromosome 2. This other gene (Raly) has the potential to encode a novel RNA-binding protein that is normally expressed in the preimplantation embryo, throughout development, and in all adult tissues examined. Importantly, the Ay mutation disrupts the structure and expression of the Raly gene. The data suggest that the Ay mutation arose from a DNA structural alteration that affects the expression of both
agouti
and Raly. We propose that the dominant pleiotropic effects associated with Ay may result from the ectopic overexpression of the wild-type a gene product under the control of the Raly promoter and that the recessive embryonic lethality may be the result of the lack of Raly gene expression in the early embryo.
...
PMID:The embryonic lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the disruption of a novel RNA-binding protein. 831 10
1
2
3
4
5
6
7
8
9
10
Next >>